C STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended											3 Months Ended		9 Months Ended
	Dec. 10, 2018	Jun. 25, 2020	May 31, 2020	May 26, 2020	May 08, 2020	Apr. 30, 2020	Apr. 20, 2020	Mar. 31, 2020	Jan. 31, 2020	Jan. 23, 2020	Dec. 31, 2019	Oct. 10, 2018	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 29, 2020	Apr. 06, 2020	Sep. 30, 2019	Jan. 09, 2019
Prepaid expenses													$ 242,000		$ 242,000				$ 230,000
Total compensation expense													$ 901,000
Common stock shares issued								630,500			606,395		38,522,236		38,522,236				35,231,776
Public offering price per share								$ 12.22	$ 9.07		$ 9.07
Proceeds from public offering			$ 1,100,000					$ 7,100,000	$ 800,000		$ 5,000,000.0				$ 184,990	$ 234,997
Additional shares of common stock								94,575	90,959		90,959
Incremental cost													$ 664,000
Interest expense													6,000		6,000
Shares to be issued													$ 110,000		$ 110,000
Performance-based stock options granted													2,559,000	3,268,362	2,561,500	3,268,862
Common stock valued													$ 385,223		$ 385,223				$ 352,318
Fair value of warrant															$ 805,753	$ 0
Warrants expired													16	26,922	1,000	29,322
Series V Warrants [Member]
Common stock price per share		$ 13.75
Expiration date description				extended the expiration date of the Series V warrants from May 28, 2020 to June 25, 2020
Fair value of warrant		$ 211,000
Warrants expired		135,963		810,127
Warrants exercised				674,164
Loss on derivatives				$ 560,000
Series V Warrants [Member] | Maximum [Member]
Common stock price per share				$ 19.75
Series V Warrants [Member] | Minimum [Member]
Common stock price per share				$ 13.75
Series N Warrants [Member]
Incremental cost										$ 22,000
Expiration date description										expiration date of the Series N warrants was extended to February 18, 2021
Series UU warrants [Member]
Incremental cost													$ 6,000		$ 6,000
Expiration date description					extended from June 11, 2020 to December 31, 2020
Warrants issued					93,593
Series YY Warrants [Member]
Warrant issued													101,839		101,839
Fair value of warrant															$ 177,000
Series XX Warrants [Member]
Common stock price per share													$ 18.00		$ 18.00
Warrant issued													461,953		461,953
Fair value of warrant															$ 629,000
Series S Warrants [Member]
Common stock price per share												$ 31.25
Warrants expired												327,729
Series DD Warrants [Member]
Common stock price per share	$ 4.50
Warrants expired	1,360,960
Series EE Warrants [Member]
Common stock price per share	$ 4.50
Warrants expired	1,360,960
Consulting Agreements [Meember]
Total expense													$ 276,000	$ 177,000	$ 623,000	$ 688,000
Consultants [Meember]
Options issued															10,000
Consultants [Meember] | Restricted Stock [Member]
Common stock issued for service, shares													14,811	20,825	47,750	161,058
Weighted average grant date fair value													$ 16.41	$ 5.62	$ 11.60	$ 3.37
Ergomed [Member]
Common stock shares held													110,521		110,521
Ergomed [Member] | SPA [Member]
Restricted shares of common stock issued																	100,000	100,000		500,000
Common stock valued																	$ 800,000	$ 1,000,000.0		$ 1,300,000
Restricted shares																	500,000	50,000
2020 Non-Qualified Stock Option Plans [Member]
Common stock price per share													$ 10.93		$ 10.93
Aggregate fair value							$ 7,881,120
Fair value price per share							$ 4.12
Performance-based stock options granted						1,872,000
Purchase shares of common stock													3,600,000		3,600,000